Package 80425-0214-2

{"route": ["ORAL"], "spl_id": "2a9aa671-d0a0-2254-e063-6294a90a9f79", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "unii": ["0H73WJJ391"], "rxcui": ["151226"], "spl_set_id": ["f16065c0-9949-9ac4-e053-2995a90a3b02"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["Advanced Rx Pharmacy of Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (80425-0214-1)", "package_ndc": "80425-0214-1", "marketing_start_date": "20230103"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (80425-0214-2)", "package_ndc": "80425-0214-2", "marketing_start_date": "20230103"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (80425-0214-3)", "package_ndc": "80425-0214-3", "marketing_start_date": "20230103"}], "brand_name": "Topiramate", "product_id": "80425-0214_2a9aa671-d0a0-2254-e063-6294a90a9f79", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "80425-0214", "generic_name": "Topiramate", "labeler_name": "Advanced Rx Pharmacy of Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Topiramate", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "50 mg/1"}], "application_number": "ANDA090162", "marketing_category": "ANDA", "marketing_start_date": "20230103", "listing_expiration_date": "20261231"}